Nattokinase is a potent fibrinolytic enzyme. Nattokinase can break down blood clots by directly hydrolyzing fibrin and plasmin substrate. Nattokinase can be used for the research of cardiovascular diseases. In Vitro Nattokinase dissolves 94% blood clot at ten minutes and degrades the fibrin clot after two hours of incubation. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Nattokinase (150-250 mg/kg; oral gavage twice daily for 2 days) exhibits fibrinolytic activity and dissolves blood clots in vivo. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Sprague-Dawley (SD) rats (180-220 g) are injected κ-CarrageenanDosage: 150, 250 mg/kg Administration: Oral gavage twice daily for 2 days Result: Increased the plasma concentration of fibrin/fibrinogen degradation products (FDPs) and D-Dimer in a dose-dependent manner. Decreased the fraction of the vessel cross section occupied by thrombosis. Form:Solid
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Nattokinase
CAS number：133876-92-3 molecular formula：
overview
compound introduction
Specs
| Chinese alias | 纳豆激酶 | ||
| English alias | - | ||
| CAS number | 133876-92-3 | molecular formula | |
| molecular weight | 517.100 g/mol | Exact mass | - |
| PSA | 168.000 Ų | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
